The Medical Research Group, Inc.

Fresno, California 93720

3 studies enrolling now · 5 studies all time

What they study most

Atrial Fibrillation, End Stage Kidney Disease, End Stage Renal Disease, Hypertension, IgA Nephropathy, Interstitial Lung Disease, Pulmonary Hypertension

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH — Recruiting now
• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy — Recruiting now
• A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen — Completed
• Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation — Completed